NCT06487455 - A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors. | Biotech Hunter

Enrollment

170

Participants

Timeline

Start Date

August 6, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Advanced Solid Tumor

Interventions

DRUG

SPH7485

SPH7485： Orally, once daily, 50-400mg, 21 days per cycle

Trial Locations (6)

RECRUITING

XiangYa Hospital CentralSouth University, Changsha

RECRUITING

Fujian Cancer Hospital, Fuzhou

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

RECRUITING

Yunnan Cancer Hospital, Kunming

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

RECRUITING

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors

lead

Shanghai Pharmaceuticals Holding Co., Ltd

INDUSTRY